Details

Autor(en) / Beteiligte

• Lobaina Mato, Yadira

Titel

Nasal route for vaccine and drug delivery: Features and current opportunities

Ist Teil von

• International journal of pharmaceutics, 2019-12, Vol.572, p.118813-118813, Article 118813

Ort / Verlag

Netherlands: Elsevier B.V

Erscheinungsjahr

2019

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• [Display omitted] •Mucosal routes reemerge as an interesting alternative for drug and vaccine delivery.•Nasal mucosa intrinsic characteristics favor drug absorption.•NALT comprises B and T cells, and a dense network of antigen presenting cells.•Nasal vaccination shows promising achievements in infectious diseases and cancer.•Nasal route may compete with oral or intravenous in systemic-acting drugs delivery.•Nose to brain delivery constitutes another appealing application of nasal route. Mucosal administration, and specifically nasal route, constitutes an alternative and promising strategy for drug and vaccine delivery. Mucosal routes have several advantages supporting their selective use for different pathologies. Currently, many efforts are being made to develop effective drug formulations and novel devices for nasal delivery. This review described the structure and main characteristics of the nasal cavity. The advantages, achievements and challenges of the nasal route use for medical purposes are discussed, with particular focus on vaccine delivery. Compelling evidences support the potentialities and safety of the nasal delivery of vaccines and drugs. This alternative route could become a solution for many unmet medical issues and also may facilitate and cheapen massive immunization campaigns or long-lasting chronic treatments. Nowadays, in spite of certain remaining skepticism, the field of nasal delivery of drugs and vaccines is growing fast, bolstered by current developments in nanotechnology, imaging and administration devices. A notable increase in the number of approved drugs for nasal administration is envisaged.